Rennes University Hospital
Rennes, 35000, France
NCT Number: NCT02112331
The optimization of newborns nutrition is a challenge especially for preterm newborns for whom nutrition plays a crucial part in cerebral and global development. Human milk is considered as the best food for newborns. Several short and long-term beneficial health effects were attributed to breastfeeding and have induced the increase of human milk in preterm newborns nutrition.
Whereas the chemical composition of infant formula has been optimized to mimic human milk, there is still a major difference between the structure of human milk and commercial infant formulas. It is well known in adult nutrition that the structure of emulsions influences their susceptibility to hydrolysis, such results have been obtained either on in vitro or in vivo studies.
Human milk is a natural emulsion (oil in water). Lipids droplets are dispersed under the form of entities called milk fat globules (average diameter 4 µm, span 0.1-20 μm). The globules are stabilized by a trilayered membrane composed mainly of polar lipids (phospholipids, sphingolipids and gangliosides), of proteins, neutral lipids and other minor compounds.
The physical treatments apply to human milk or more generally to bovine milk to pasteurize or stabilize the milk modify the structure of the natural emulsion. Heat treatment for instance induces whey proteins denaturation and the adsorption of protein aggregates on the surface of the milk fat globules. Heat treatment also leads to the denaturation of bile salt stimulated lipase. These effects limit intragastric lipolysis in preterm newborns.
Conversely, reduction of milk globules size, by homogenisation of milk, increases the specific surface available for lipase adsorption and limits the lost of fat during enteral administration of milk. Such treatment could thus enhance gastric lipolysis and improve fat absorption of preterm newborns.
The objective of this trial is to evaluate the effects of physical treatments (pasteurization and homogenisation by ultrasonication) applied to human milk on gastric lipolysis and milk destructuration. This trial is conducted, in vivo, on preterm newborns.
Looking for future studies?
Notify Me5 day–21 day
All sexes
Interventional
Not applicable
Rennes, 35000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 35 min
Monitoring of the lipolysis kinetics, using chromatography methods
Time frame: 35 min, 60 min, 90 min
Time frame: 35 min, 60 min, 90 min
Fat composition by chromatographic techniques : High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC)
Time frame: 35 min, 60 min, 90 min
Lipolysis products by thin layer chromatography (TLC), gas chromatography (GC) and IATROSCAN
Time frame: 35 min, 60 min, 90 min
Proteolysis products by electrophoresis (SDS-Page) and free amino acids by chromatography (HPLC)
Time frame: 35 min, 60 min, 90 min
Evaluation of the kinetic of the gastric emptying by measuring the volume remaining in the stomach
Time frame: 35 min, 60 min, 90 min
Comparison of lipolysis level obtained either on in vitro or in vivo studies
Time frame: 60 min, 90 min
Time frame: 35 min, 60 min, 90 min
Monitoring of the lipolysis kinetics, using chromatography methods
Rennes University Hospital
Other
Acronym: ARCHILACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718516
Body Weight, Body Weight Changes
New York, United States
View Trial DetailsNCT03673709
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Blantyre, Malawi
View Trial DetailsNCT07693530
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07661511
Female Urogenital Diseases and Pregnancy Complications, Hypothermia Neonatal
Querétaro, Mexico
View Trial Details